Product Information
PNV-DHA SOFTGEL is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.9857 per EA under NDC 42192032130. Its NADAC has been published 460 times since Nov 28, 2013.
PNV-DHA SOFTGEL
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexentStrength
10; 85; 140; 200; 12; 300; 27; 1; 45; 25 [iU]/1; [iU]/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; [iU]/1
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192032130
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM; CHOLECALCIFEROL; CYANOCOBALAMIN; DOCONEXENT; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM; PYRIDOXINEApproval Type
Unapproved
On Market Since
11/2/2009
Pharmacological Classes
Price Statistics
The NADAC for PNV-DHA SOFTGEL has been published 460 times since Nov 28, 2013, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9857 per EA |
|---|---|
| All-time high | $1.3305 (Dec 14, 2022) |
| All-time low | $0.6542 (Jul 17, 2024) |
| 52-week high | $1.0065 |
| 52-week low | $0.9110 |
| Median price | $0.9678 |
| Average price | $0.9851 |
| Largest weekly change | +33.0% (Oct 19, 2022) |
| Weeks tracked | 460 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin B12 class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PNV-DHA SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for PNV-DHA SOFTGEL, manufactured by Acella Pharmaceuticals, LLC, is $0.9857 per EA (NDC 42192032130), effective Sep 30, 2026.
How has the price of PNV-DHA SOFTGEL changed over time?
Over the history we have for it, the NADAC for PNV-DHA SOFTGEL has declined 18.2%. It has been tracked across 460 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PNV-DHA SOFTGEL?
Since Nov 28, 2013, the NADAC for PNV-DHA SOFTGEL has ranged from a low of $0.6542 (Jul 17, 2024) to a high of $1.3305 (Dec 14, 2022), with a median of $0.9678 per EA.
Are there cheaper alternatives to PNV-DHA SOFTGEL?
No other NADAC-published product currently shares the active ingredient and strength of PNV-DHA SOFTGEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PNV-DHA SOFTGEL?
PNV-DHA SOFTGEL (NDC 42192032130) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.